brivaracetam

FDA Drug Profile — brivaracetam, BRIVARACETAM, Briviact, Brivaracetam

Drug Details

Generic Name
brivaracetam
Brand Names
brivaracetam, BRIVARACETAM, Briviact, Brivaracetam
Application Number
ANDA214748
Sponsor
SolarisPharmaCorporation
NDC Codes
33
Dosage Forms
TABLET, FILM COATED, SOLUTION, POWDER, INJECTION, INJECTION, SUSPENSION
Routes
ORAL, INTRAVENOUS
Active Ingredients
BRIVARACETAM

Indications and Usage

1 INDICATIONS AND USAGE Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )